JAK inhibitors

Keywords:
#
AAD 2024
#
Tissue Classifier
#
Conferences
#
Skin Care
#
AAD 2023
#
BioJapan2022
#
Safety monitoring
No items found.
SCARLETRED used in Janus kinase inhibitor safety testing and monitoring
Article
•
Aug 14, 2023

SCARLETRED skin monitoring helps to make treatments with JAK inhibitors safer

With patient safety in mind, SCARLETRED®Vision can be used as a digital aid to measure and document treatment safety and efficacy of newly developed JAK inhibitors either on site and/or home based clinical trials.
Paper
•
November 30, 2023

Automated Classification of Hidradenitis Suppurativa Disease Severity by Convolutional Neural Network Analyses Using Calibrated Clinical Images

Read more